Clinical trial research in focus: improving drug development and trial design in pulmonary arterial hypertension

2017 ◽  
Vol 5 (7) ◽  
pp. 544-546 ◽  
Author(s):  
Annie Christine Lajoie ◽  
Sebastien Bonnet ◽  
Steeve Provencher
Keyword(s):  
Clinical Trial ◽  
Pulmonary Arterial Hypertension ◽  
Drug Development ◽  
Arterial Hypertension ◽  
Trial Design ◽  
Clinical Trial Research ◽  
Pulmonary Arterial

scholarly journals End Points and Clinical Trial Design in Pulmonary Arterial Hypertension

2009 ◽  
Vol 54 (1) ◽  
pp. S97-S107 ◽  
Author(s):  
Vallerie V. McLaughlin ◽  
David B. Badesch ◽  
Marion Delcroix ◽  
Thomas R. Fleming ◽  
Sean P. Gaine ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Trial Design ◽  
Clinical Trial Design ◽  
End Points ◽  
Pulmonary Arterial

scholarly journals Double-Blind, Placebo-Controlled Clinical Trial With a Rho-Kinase Inhibitor in Pulmonary Arterial Hypertension

2013 ◽  
Vol 77 (10) ◽  
pp. 2619-2625 ◽  
Author(s):  
Yoshihiro Fukumoto ◽  
Norikazu Yamada ◽  
Hiromi Matsubara ◽  
Minori Mizoguchi ◽  
Kazuaki Uchino ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Kinase Inhibitor ◽  
Rho Kinase ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Rho Kinase Inhibitor ◽  
Pulmonary Arterial

scholarly journals Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development

2017 ◽  
Vol 282 (2) ◽  
pp. 129-141 ◽  
Author(s):  
P. Ghataorhe ◽  
C. J. Rhodes ◽  
L. Harbaum ◽  
M. Attard ◽  
J. Wharton ◽  
...  
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Drug Development ◽  
Arterial Hypertension ◽  
Pulmonary Arterial
Sign in / Sign up

Export Citation Format

Share Document